These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 862332)

  • 1. Sodium restriction and inhibition of the renin-angiotensin system in renovascular hypertension in the rat.
    Swales JD; Thurston H
    Clin Sci Mol Med; 1977 Apr; 52(4):371-5. PubMed ID: 862332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of administration of Sar1-Ala8-angiotensin II during the development and maintenance of renal hypertension in the rat.
    Fernandes M; Fiorentini R; Onesti G; Bellini G; Gould AB; Hessan H; Kim KE; Swartz C
    Clin Sci Mol Med; 1978 Jun; 54(6):633-7. PubMed ID: 657733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood pressure response of nephrectomized hypertensive rats to converting enzyme inhibition: evidence for persistent vascular renin activity.
    Thurston H; Swales JD
    Clin Sci Mol Med; 1977 Mar; 52(3):299-304. PubMed ID: 844262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
    Bing RF; Russell GI; Swales JD; Thurston H
    J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of sodium retention in Goldblatt 2-kidney hypertension in the rat.
    Thurston H; Swales JD
    Clin Sci Mol Med Suppl; 1976 Dec; 3():125s-127s. PubMed ID: 1071586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasodepressor property of the converting enzyme inhibitor captopril (SQ 14 225): the role of factors other than renin-angiotensin blockade in the rat.
    Marks ES; Bing RF; Thurston H; Swales JD
    Clin Sci (Lond); 1980 Jan; 58(1):1-6. PubMed ID: 6986224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of chronic renovascular hypertension to surgical correction or prolonged blockade of the renin-angiotensin system by two inhibitors in the rat.
    Thurston H; Bing RF; Marks ES; Swales JD
    Clin Sci (Lond); 1980 Jan; 58(1):15-20. PubMed ID: 6986225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium retention versus renin-angiotensin system in experimental renal hypertension.
    Liard JF
    Can J Physiol Pharmacol; 1973 Mar; 51(3):238-41. PubMed ID: 4350180
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetic and pharmacodynamic studies of infusions with [Sar 1, Val5, Ala8] angiotensin II (saralasin).
    Gless KH; Bönner G; Gram N; Mann JF; Helber A; Ganten D
    Klin Wochenschr; 1978; 56 Suppl 1():97-105. PubMed ID: 732257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemodynamic effects of sar1-ala8-angiotensin in patients with renovascular hypertension (author's transl)].
    Philipp T; Zschierdrich H; Distler A
    Klin Wochenschr; 1977 Sep; 55(18):917-9. PubMed ID: 916618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurogenic activity--angiotensin II interaction during the development and maintenance of renal hypertension in the rat.
    Bellini G; Fiorentini R; Fernandes M; Onesti G; Hessan H; Gould AB; Bianchi M; Kim KE; Swartz C
    Clin Sci (Lond); 1979 Jul; 57(1):25-9. PubMed ID: 477245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin, sodium, and vasodepressor response to saralasin in renovascular and essential hypertension.
    Marks LS; Maxwell MH; Kaufman JJ
    Ann Intern Med; 1977 Aug; 87(2):176-82. PubMed ID: 889198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of angiotensin conversion and prevention of renal hypertension.
    Miller ED; Samuels AI; Haber E; Barger AC
    Am J Physiol; 1975 Feb; 228(2):448-53. PubMed ID: 235218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II blockade in normal subjects and essential hypertensive patients.
    MacGregor GA; Dawes PM
    Clin Sci Mol Med Suppl; 1976 Dec; 3():193s-196s. PubMed ID: 1071606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of varying sodium intake on blood pressure and renin-angiotensin system in subtotally nephrectomized rats.
    Ylitalo P; Hepp R; Möhring J; Gross F
    J Lab Clin Med; 1976 Nov; 88(5):807-16. PubMed ID: 978043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypotensive action of captopril and saralasin in intact and anephric spontaneously hypertensive rats.
    Hutchinson JS; Mendelsohn FA; Doyle AE
    Hypertension; 1980; 2(2):119-24. PubMed ID: 6991407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exchangeable sodium in angiotensinogenic and nonangiotensinogenic renovascular hypertension.
    Albertini R; Binia A; Otsuka Y; Carretero OA
    Hypertension; 1979; 1(6):624-30. PubMed ID: 232088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of renin-angiotensin system in chronic renal hypertensive rats.
    Sen S; Smeby RR; Bumpus FM; Turcotte JG
    Hypertension; 1979; 1(4):427-34. PubMed ID: 232087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II blockade before and after marked sodium depletion in patients with hypertension.
    Van Hoogdalem P; Donker AJ; Leenen FH
    Clin Sci Mol Med; 1978 Jan; 54(1):75-83. PubMed ID: 620496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.
    Case DB; Wallace JM; Keim HJ; Weber MA; Drayer JI; White RP; Sealey JE; Laragh JH
    Am J Med; 1976 Nov; 61(5):790-6. PubMed ID: 185903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.